Accession Number:

AD1034184

Title:

Defense Health Board Review of the U.S. Army Center for Health Promotion and Preventive Medicine Assessment of Sodium Dichromate Exposure at Qarmat Ali Water Treatment Plant

Descriptive Note:

Technical Report

Corporate Author:

DEFENSE HEALTH BOARD FALLS CHURCH VA FALLS CHURCH United States

Personal Author(s):

Report Date:

2008-12-19

Pagination or Media Count:

16.0

Abstract:

At the request of LTG Eric B. Schoomaker, the Surgeon General of the Army, the Defense Health Board DHB conducted an external review of a U.S. Army Center for Health Promotion and Preventive Medicine USACHPPM occupational and environmental health assessment conducted in 2003 at the Qarmat Ali Water Treatment Plant WTP in Basra, Iraq to address a potential sodium dichromate exposure to United States military service members. The DHB was asked to opine on whether the medical evaluations conducted by USACHPPM were comprehensive and appropriate to address the potential exposure of U.S. military and Department of Army civilian personnel to sodium dichromate, to identify lessons learned, and to provide recommendations for improving the Departments policies and procedures. The DHB Military Occupational and Environmental Health and Medical Surveillance Subcommittee reviewed the classified final report, Deployment Occupational and Environmental Health Survey and Operational Health Risk Assessment, Qarmat Ali Industrial Water Treatment Plant, Basra, Iraq which included exposure, medical, epidemiologic, and health risk assessments, as well as information pertaining to health communication efforts undertaken by the USACHPPM Occupational and Environmental Health and Safety OEHSTeam. The Subcommittee found the risk assessment timely, comprehensive and appropriate for the potential risk posed to the service members. The comprehensive environmental health assessment including soil and air sampling conducted within weeks of first notification revealed minimal levels of Chromium Cr VI.

Subject Categories:

  • Inorganic Chemistry
  • Pharmacology

Distribution Statement:

APPROVED FOR PUBLIC RELEASE